|
|
|||||||
| |||||||
| |||||||
| 1 | SENATE RESOLUTION
| ||||||
| 2 | WHEREAS, More than 20 million Americans, about one in nine | ||||||
| 3 | adults, have a form of chronic kidney disease; of these, more | ||||||
| 4 | than eight million have seriously reduced kidney functions | ||||||
| 5 | that, if left untreated, may progress to a more severe level of | ||||||
| 6 | chronic kidney disease; and
| ||||||
| 7 | WHEREAS, Chronic kidney disease and the resultant | ||||||
| 8 | progression of that disease to stage 5 chronic kidney disease, | ||||||
| 9 | known as End Stage Renal Disease (ESRD), affect over 300,000 | ||||||
| 10 | Americans, of whom over 12,800 are Illinoisans; and | ||||||
| 11 | WHEREAS, People over the age of 50 and those who have a | ||||||
| 12 | family history of kidney disease or have been diagnosed with | ||||||
| 13 | diabetes or hypertension are more likely to develop chronic | ||||||
| 14 | kidney disease; and | ||||||
| 15 | WHEREAS, Certain populations are disproportionately | ||||||
| 16 | impacted; African Americans make up 15.5% of the general | ||||||
| 17 | population of Illinois but account for 42.1% of Illinoisans | ||||||
| 18 | with stage 5 chronic kidney disease or End Stage Renal Disease; | ||||||
| 19 | and
| ||||||
| 20 | WHEREAS, Stage 5 chronic kidney disease or End Stage Renal | ||||||
| 21 | Disease is three times more likely to occur in Hispanics and | ||||||
| 22 | Native Americans and two times more likely in Asian Americans | ||||||
| 23 | than in Caucasians; and | ||||||
| 24 | WHEREAS, 95% of all stage 5 chronic kidney disease patients | ||||||
| 25 | are either Medicare beneficiaries through a unique federal | ||||||
| 26 | program or Medicaid beneficiaries representing a significant | ||||||
| 27 | cost to the State, and, according to the United States Renal | ||||||
| 28 | Data Service, these yearly expenditures amount to about $60,000 | ||||||
| 29 | per Illinoisan and are growing each year; and | ||||||
| |||||||
| |||||||
| 1 | WHEREAS, The combined financial impact of this devastating | ||||||
| 2 | disease on Illinois' health care system is over $768 million | ||||||
| 3 | annually; and
| ||||||
| 4 | WHEREAS, The two contributing factors accounting for more | ||||||
| 5 | than 60% of new cases of chronic kidney disease are diabetes | ||||||
| 6 | and hypertension; and | ||||||
| 7 | WHEREAS, Chronic kidney disease may lead to cardiovascular | ||||||
| 8 | complications, bone disease, and irreversible kidney failure; | ||||||
| 9 | and | ||||||
| 10 | WHEREAS, A person may exhibit no symptoms of chronic kidney | ||||||
| 11 | disease until 75% or more of kidney function is lost and this | ||||||
| 12 | devastating disease can be prevented through early screening | ||||||
| 13 | and proper education; and
| ||||||
| 14 | WHEREAS, Simple, cost-effective means are available to | ||||||
| 15 | identify and diagnose chronic kidney disease and associated | ||||||
| 16 | life-threatening complications; and | ||||||
| 17 | WHEREAS, Cost-effective means can determine levels of | ||||||
| 18 | kidney function and provide information for clinicians about | ||||||
| 19 | therapeutic interventions that may preserve kidney function, | ||||||
| 20 | sustain life, and delay progression to stage 5 chronic kidney | ||||||
| 21 | disease or renal transplantation, or both; and | ||||||
| 22 | WHEREAS, Evidence-based clinical guidelines have been | ||||||
| 23 | developed by scientists and renal experts and published in | ||||||
| 24 | peer-reviewed journals; therefore, be it
| ||||||
| 25 | RESOLVED, BY THE SENATE OF THE NINETY-THIRD GENERAL | ||||||
| 26 | ASSEMBLY OF THE STATE OF ILLINOIS, that we request the Illinois | ||||||
| 27 | Department of Public Aid to institute a program by which | ||||||
| 28 | individuals who have been diagnosed with diabetes or | ||||||
| 29 | hypertension or who have a family history of kidney disease and | ||||||
| |||||||
| |||||||
| 1 | receive a diagnosis of kidney disease shall be classified as | ||||||
| 2 | chronic kidney disease patients; and be it further
| ||||||
| 3 | RESOLVED, That these patients shall be evaluated for kidney | ||||||
| 4 | disease through routine clinical laboratory assessments of | ||||||
| 5 | kidney function and that the diagnostic criteria that define | ||||||
| 6 | chronic kidney disease shall be any generally-recognized | ||||||
| 7 | clinical practice guidelines that identify chronic kidney | ||||||
| 8 | disease based on the presence of kidney damage and the level of | ||||||
| 9 | kidney function; and be it further | ||||||
| 10 | RESOLVED, That chronic kidney patients shall receive | ||||||
| 11 | coverage for diagnostic testing and healthcare services that | ||||||
| 12 | have been certified by the patient's physician as having | ||||||
| 13 | clinical benefit for: (1) managing risk factors that prolong | ||||||
| 14 | kidney function or delay progression to kidney replacement | ||||||
| 15 | therapy; (2) managing risk factors for bone disease and | ||||||
| 16 | cardiovascular disease associated with chronic kidney disease; | ||||||
| 17 | (3) improving nutritional status of chronic kidney disease | ||||||
| 18 | patients; and (4) correcting anemia associated with chronic | ||||||
| 19 | kidney disease; and be it further | ||||||
| 20 | RESOLVED, That a copy of this resolution be delivered to | ||||||
| 21 | the Director of the Illinois Department of Public Aid.
| ||||||